Fostamatinib

Indication

Treating refractory chronic immune thrombocytopenia - NICE TA835

Red

Brand:

Nice TA:

835

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Blood and Nutrition

1.1 Fostamatinib is recommended as an option for treating refractory chronic immune thrombocytopenia (ITP) in adults, only if:

they have previously had a thrombopoietin receptor agonist (TPO‑RA), or a TPO‑RA is unsuitable
the company provides fostamatinib according to the commercial arrangement.

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 14 - Nov - 2022